PRE 14A

PRE 14A Filing

Company: Eloxx Pharmaceuticals, Inc.
Filed: July 30, 2009
Period of Report: July 30, 2009
Accession Number: 0001144204-09-039535

View Document ↗ View on SEC.gov ↗